Across TCGA pan-cancer cohorts, NSUN3 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated NSUN3 data layer compared with 20 for mass-spec protein and 5 for mutation status.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher NSUN3 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated NSUN3 expression acts as an unfavorable survival marker.
HNSC and LSCC are the cancer types where NSUN3 mass-spec protein most reproducibly stratifies survival.